Women who undergo menopause as a result of hysterectomy can sometimes be at higher risk for osteoporosis (bone loss), especially if they endure fluctuating levels of hormones including estrogen. In some cases, women can undergo estradiol hormone replacement therapy to counteract bone loss and boost estrogen levels in their bodies.

A recent study was conducted to examine the effects of estradiol hormone therapy on bone and cardiovascular health in 12 women who were experiencing menopause as a result of undergoing hysterectomy. The estradiol therapy was administered to each woman in the form of pellet implants injected into the skin. At the end of the study, it was found that this particular form of estradiol hormone replacement therapy did not have adverse effects on bone and cardiovascular health in menopausal women.

To learn more about this study, please visit: Bone and cardiovascular health not affected by estradiol hormone therapy